James A. Star
Known title: DirectorCIK: 0001260705
James A. Star's purchase track record
How the stock did after each of James A. Star's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since December 20, 2021
Stock higher 6 months later
67%
3 months: 33%
Median 6-month return
+15.4%
3 months: -9.2%
Beat the S&P 500
33%
median -0.4% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/12/2023 | CHWY | $551K | -9.2% | +15.4% | +15.8% |
| 6/6/2022 | CHWY | $9.98M | +19.0% | +56.0% | -3.0% |
| 12/20/2021 | CHWY | $1.79M | -27.0% | -43.6% | -17.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| CHWY | ▲ Buy | Grant | 10,665 | $0 | 7/9/2026 | View on chart |
| CHWY | ▲ Buy | Grant | 4,921 | $0 | 7/14/2025 | View on chart |
| CHWY | ▲ Buy | Grant | 8,133 | $0 | 7/16/2024 | View on chart |
| CHWY | ▲ Buy | Open Market | 12,242 | $250K | 12/14/2023 | View on chart |
| CHWY | ▲ Buy | Open Market | 15,353 | $301K | 12/12/2023 | View on chart |
| CHWY | ▲ Buy | Grant | 4,880 | $0 | 7/17/2023 | View on chart |
| CHWY | ▲ Buy | Grant | 5,145 | $0 | 7/21/2022 | View on chart |
| CHWY | ▲ Buy | Open Market | 13,500 | $363K | 6/13/2022 | View on chart |
| CHWY | ▲ Buy | Open Market | 167,978 | $4.6M | 6/13/2022 | View on chart |
| CHWY | ▲ Buy | Open Market | 36,127 | $1.0M | 6/6/2022 | View on chart |
| CHWY | ▲ Buy | Open Market | 144,509 | $4.0M | 6/6/2022 | View on chart |
| CHWY | ▲ Buy | Open Market | 5,400 | $296K | 12/21/2021 | View on chart |
| CHWY | ▲ Buy | Open Market | 9,732 | $535K | 12/20/2021 | View on chart |
| CHWY | ▲ Buy | Open Market | 17,146 | $963K | 12/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Chewy vet care growth offsets Mizuho price target cut
Chewy reported triple-digit growth in its vet care segment as clinic scale builds. Meanwhile, Mizuho maintained an Outperform rating but lowered its price target to $28. The stock currently trades near its 52-week low, reflecting mixed sentiment despite positive operational updates.
Chewy vet care growth offsets Mizuho price target cut. Chewy reported triple-digit growth in its vet care segment as clinic scale builds. Meanwhile, Mizuho maintained an Outperform rating but lowered its price target to $28. The stock currently trades near its 52-week low, reflecting mixed sentiment despite positive operational updates.